Cancer Screening Training for Academics

June 5, 2026 updated by: Naciye Esra Koyuncu, KTO Karatay University

The Effect of Cancer Screening Training Provided to Academics at a Foundation University on Cancer Screening Knowledge Levels and Family Health Center Utilization Rates

Purpose: The purpose of this research is to examine the effect of cancer screening education on individuals' knowledge levels regarding cancer screening and their rates of utilization of primary health care services.

Method: The research was conducted using a parallel group pretest-posttest experimental design. The study, conducted at a foundation university between April and May 2025, included 71 academics selected using simple random sampling. The intervention group received structured cancer screening education for four weeks. Data will be collected using a Personal Information Form and the Cancer Screening Knowledge Scale (CSKS), and will be analyzed using appropriate statistical methods.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Akabe
      • Konya, Akabe, Turkey (Türkiye), 42080
        • KTO Karatay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Be employed full-time at the university,
  • Be able to read and understand Turkish,
  • Not have received any cancer screening training in the last 6 months

Exclusion Criteria:

  • Those who did not participate in the training or participated incompletely,
  • Those with incomplete information in the pre-test or post-test data,
  • Those who have been diagnosed with cancer and are undergoing treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Before the training began, baseline data were collected from participants in the intervention group, including a Personal Information Form, a Cancer Screening Awareness Questionnaire for Family Health Centers, and a Cancer Screening Knowledge Scale. Completing the baseline assessment took approximately 5-10 minutes. Subsequently, this group received a 15-minute face-to-face structured training session on cancer screening and the use of Family Health Centers. The post-test was administered two months after the training was completed.
Pre-test data, including the Personal Information Form and the Cancer Screening Information Scale, were collected from participants in the intervention group before the training began. The pre-test took approximately 5-10 minutes to complete. Subsequently, this group received training on cancer screening and Family Health Centre use once a week for a total of four weeks. Following the completion of the training, a post-test was administered at the end of the fourth week.
No Intervention: control
No training was provided to participants in the control group. Participants in this group were only asked to complete a Personal Information Form at the beginning of the study, and final test data was collected at the end of the two months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family health centre utilisation rate
Time Frame: From baseline to 2 months after training
Awareness Rate of Cancer Screenings at Family Health Centers: The percentage of participants who reported having utilized the services provided by a family health center within a specific time period. This rate includes visits for preventive care, screening, diagnosis, treatment, or follow-up services, as defined in the study protocol.
From baseline to 2 months after training
Cancer knowledge level
Time Frame: From baseline to 2 month post-training
Cancer knowledge level: The score obtained from the Cancer Screening Knowledge Scale (CSKS), which measures participants' knowledge about cancer screening methods, recommended screening intervals, and target populations. Higher scores indicate a greater level of knowledge, as defined by the study protocol.
From baseline to 2 month post-training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Dagar, M., Upadhyay, P., & Kumar, P. (2025). Assessing Cancer Awareness and Knowledge Among Healthcare Professionals in a Tertiary Care Teaching Hospital, Bareilly. SRMS JOURNAL OF MEDICAL SCIENCE, 10(Suppl1), S13-S19. https://doi.org/10.21761/JMS.V10ISUPPL.04

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Actual)

June 1, 2025

Study Completion (Actual)

June 1, 2025

Study Registration Dates

First Submitted

August 1, 2025

First Submitted That Met QC Criteria

November 19, 2025

First Posted (Actual)

November 28, 2025

Study Record Updates

Last Update Posted (Actual)

June 9, 2026

Last Update Submitted That Met QC Criteria

June 5, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

"Individual participant data will not be shared due to privacy concerns and institutional ethical restrictions. The dataset includes identifiable information that cannot be fully anonymized.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Cancer training

Subscribe